Majid Sabhiya, Farooq Rabia, Khan Mosin S, Rashid Samia, Bhat Showkat A, Wani Hilal A, Qureshi Waseem
Department of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.
Department of Basic Medical Sciences, University of Bisha, Bisha, 67714 Saudi Arabia.
SN Compr Clin Med. 2020;2(10):1767-1776. doi: 10.1007/s42399-020-00457-z. Epub 2020 Aug 25.
Coronavirus disease 2019 (COVID-19), an ongoing global health emergency, is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging in Wuhan, China, in December 2019, it spread widely across the world causing panic-worst ever economic depression is visibly predictable. Coronaviruses (CoVs) have emerged as a major public health concern having caused three zoonotic outbreaks; severe acute respiratory syndrome-CoV (SARS-CoV) in 2002-2003, Middle East respiratory syndrome-CoV (MERS-CoV) in 2012, and currently this devastating COVID-19. Research strategies focused on understanding the evolutionary origin, transmission, and molecular basis of SARS-CoV-2 and its pathogenesis need to be urgently formulated to manage the current and possible future coronaviral outbreaks. Current response to the COVID-19 outbreak has been largely limited to monitoring/containment. Although frantic global efforts for developing safe and effective prophylactic and therapeutic agents are on, no licensed antiviral treatment or vaccine exists till date. In this review, research strategies for coping with COVID-19 based on evolutionary and molecular aspects of coronaviruses have been proposed.
2019冠状病毒病(COVID-19)是一场持续的全球卫生突发事件,是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的一种高度传染性和致病性的病毒感染。2019年12月在中国武汉出现后,它在全球广泛传播,导致了恐慌——有史以来最严重的经济衰退显然是可以预见的。冠状病毒(CoV)已成为一个主要的公共卫生问题,曾引发三次人畜共患病疫情;2002 - 2003年的严重急性呼吸综合征冠状病毒(SARS-CoV)、2012年的中东呼吸综合征冠状病毒(MERS-CoV),以及目前这场毁灭性的COVID-19。迫切需要制定侧重于了解SARS-CoV-2的进化起源、传播、分子基础及其发病机制的研究策略,以应对当前及未来可能出现的冠状病毒疫情。目前对COVID-19疫情的应对主要局限于监测/控制。尽管全球正在疯狂努力研发安全有效的预防和治疗药物,但迄今为止尚无获得许可的抗病毒治疗方法或疫苗。在这篇综述中,基于冠状病毒的进化和分子方面,提出了应对COVID-19的研究策略。